MATLIN DAVID J — SEC Form 4 filings
SEC reporting owner CIK 1251956. 21 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-03-12 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 125,640 shares, $655,123 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 92,307 shares @ $4.75 ($438,458) in Clene Inc., filed 2024-10-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | Director | 15 | 2 legs · 125,640 sh · $655,123 | — | 18 |
| TriSalus Life Sciences, Inc. (TLSI) | Director | 6 | — | — | 9 |
Form 4 filings — MATLIN DAVID J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Clene Inc. (CLNN) | Grant/award (A): 434,451 @ $3.28 | EDGAR |
| 2026-08-14 | 4 | Clene Inc. (CLNN) | Grant/award (A): 6,230 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Clene Inc. (CLNN) | Grant/award (A): 1,500 (derivative) @ $0 · Grant/award (A): 3,659 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 28,201 @ $0 · Grant/award (A): 23,065 @ $0 · Grant/award (A): 56,403 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Conversion (C): 330,000 @ $0 · Conversion (C): 100,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Clene Inc. (CLNN) | Grant/award (A): 5,372 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Clene Inc. (CLNN) | Purchase (P): 33,333 @ $6.50 · Grant/award (A): 40,000 (derivative) · Grant/award (A): 93,333 (derivative) | EDGAR |
| 2025-11-14 | 4 | Clene Inc. (CLNN) | Grant/award (A): 3,692 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Clene Inc. (CLNN) | Grant/award (A): 7,255 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Clene Inc. (CLNN) | Grant/award (A): 10,209 (derivative) @ $0 · Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | Clene Inc. (CLNN) | Grant/award (A): 5,628 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Other (J): 89,501 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 10,040 @ $0 | EDGAR |
| 2024-12-09 | 4 | Clene Inc. (CLNN) | Grant/award (A): 5,563 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Clene Inc. (CLNN) | Grant/award (A): 4,990 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Clene Inc. (CLNN) | Purchase (P): 92,307 @ $4.75 · Grant/award (A): 92,307 (derivative) @ $0.12 | EDGAR |
| 2024-08-21 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Clene Inc. (CLNN) | Grant/award (A): 65,723 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Clene Inc. (CLNN) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Clene Inc. (CLNN) | Grant/award (A): 57,488 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1251956 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →